Trang kết quả 11 cho Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (1012)
- Úc (58)
- Áo (16)
- Bỉ (7)
- Brazil (16)
- Canada (83)
- Trung Quốc (94)
- Đan Mạch (6)
- Phần Lan (4)
- Pháp (41)
- Đức (738)
- Hồng Kông (46)
- Ấn Độ (19)
- Ai-len (1)
- Israel (19)
- Ý (4)
- Nhật Bản (37)
- Mexico (28)
- Hà Lan (3)
- New Zealand (1)
- Na Uy (14)
- Ba Lan (9)
- Nga (2)
- Hàn Quốc (12)
- Tây Ban Nha (4)
- Thụy Điển (70)
- Thụy Sĩ (11)
- Đài Loan (67)
- Thái Lan (2)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (69)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Chăm sóc sức khỏe (2611)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (2611)
Công nghệ sinh học (2611)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2611)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1705)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (553)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (419)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (501)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| U.S. Stem Cell USRM | $0 — |
-99
|
$641 — | $20K — | $0 — | $0.0001 — | $641 — | 0 | $0 — | |
| NLS Pharmaceutics NLSPW | $0.02 — |
-34.15
|
$0 — | $58.77K — | $0.02 — | $0.02 — | $0 — | 0 | $0 — | |
| Novo Nordisk A/S N1VO34.SA | $50.85 10.31 USD |
-1.26
|
$1.81T 366.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.81T 366.36B USD | 20.09 | $2.53 0.51 USD | |
| Novo Nordisk A/S NOVA.F | $63.1 68.98 USD |
+0.16
|
$284.44B 310.93B USD | $529 578.27 USD | $63 68.87 USD | $64.4 70.4 USD | $284.44B 310.93B USD | 20.03 | $3.15 3.44 USD | |
| Novo Nordisk A/S NVON.MX | $1,394.71 82.58 USD |
+0.27
|
$3.22T 190.45B USD | $1.83K 108.36 USD | $1,385.01 82.01 USD | $1,405.99 83.25 USD | $3.22T 190.45B USD | 22.46 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $8,784 520.12 USD |
0
|
$2.26T 133.57B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.26T 133.57B USD | 0 | -$73.79 -4.3 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $624.64 126.6 USD |
-1.39
|
$645.83B 130.9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $645.83B 130.9B USD | 0 | -$5.37 -1.08 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $390.55 426.92 USD |
-0.04
|
$100.54B 109.91B USD | $5 5.47 USD | $389.8 426.1 USD | $390.55 426.92 USD | $100.54B 109.91B USD | 0 | -$3.36 -3.6 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $389.55 425.83 USD |
-1
|
$100.04B 109.35B USD | $107 116.97 USD | $381.5 417.03 USD | $393.6 430.26 USD | $100.04B 109.35B USD | 0 | -$3.35 -3.6 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $389.2 425.45 USD |
-0.71
|
$99.95B 109.25B USD | $110 120.24 USD | $382.6 418.23 USD | $392 428.51 USD | $99.95B 109.25B USD | 0 | -$3.35 -3.6 USD | |
| CSL CMXHF | $158.4 — |
-3.97
|
$77.08B — | $5.15K — | $158.4 — | $164.98 — | $77.08B — | 29.06 | $5.45 — | |
| CSL Limited CSJ.F | $137.14 149.91 USD |
-1.21
|
$66.89B 73.12B USD | $50 54.66 USD | $136.78 149.52 USD | $137.14 149.91 USD | $66.89B 73.12B USD | 28.63 | $4.79 5.24 USD | |
| CSL Limited CSJA.F | $68 74.33 USD |
-1.45
|
$66.73B 72.95B USD | $5 5.47 USD | $68 74.33 USD | $68 74.33 USD | $66.73B 72.95B USD | 28.45 | $2.39 2.61 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $45.21 9.16 USD |
-0.62
|
$295.33B 59.86B USD | $0 0 USD | $0 0 USD | $0 0 USD | $295.33B 59.86B USD | 12.25 | $3.69 0.75 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $9,485 561.63 USD |
0
|
$1.01T 59.69B USD | $178 10.54 USD | $0 0 USD | $0 0 USD | $1.01T 59.69B USD | 12.51 | $757.85 44.87 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,019,000 769.18 USD |
-1.45
|
$72.53T 54.75B USD | $96.96K 73.19 USD | $1,015,000 766.16 USD | $1,040,000 785.03 USD | $72.53T 54.75B USD | 0 | $0 0 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $427.2 466.99 USD |
-1.54
|
$45.66B 49.92B USD | $0 0 USD | $420.7 459.88 USD | $429.9 469.94 USD | $45.66B 49.92B USD | 12.36 | $34.56 37.78 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $86.26 17.48 USD |
-0.02
|
$224.95B 45.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $224.95B 45.59B USD | 0 | -$0.6 -0.1 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| argenx SE A1RG34.SA | $131.95 26.74 USD |
0
|
$201.42B 40.82B USD | $0 0 USD | $0 0 USD | $0 0 USD | $201.42B 40.82B USD | 35.75 | $3.69 0.75 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $264.9 289.57 USD |
+0.08
|
$35.15B 38.42B USD | $37 40.45 USD | $264.9 289.57 USD | $264.9 289.57 USD | $35.15B 38.42B USD | 0 | -$1.83 -2.0004 USD | |
| argenx SE ARGNF | $562 — |
+2
|
$35.63B — | $10 — | $562 — | $562 — | $35.63B — | 34.24 | $16.41 — | |
| UCB SA UCBJF | $179.39 — |
+2.07
|
$34.59B — | $84 — | $179.39 — | $179.39 — | $34.59B — | 28.74 | $6.24 — | |
| argenx SE 1AEA.F | $496 542.2 USD |
-0.8
|
$30.87B 33.74B USD | $9 9.84 USD | $496 542.2 USD | $496 542.2 USD | $30.87B 33.74B USD | 34.44 | $14.4 15.74 USD | |
| argenx SE 1AE.F | $502 548.75 USD |
-1.1
|
$30.77B 33.64B USD | $10 10.93 USD | $502 548.75 USD | $502 548.75 USD | $30.77B 33.64B USD | 34.81 | $14.42 15.76 USD | |
| argenx SE ARGX.VI | $500.2 546.79 USD |
-1.57
|
$30.63B 33.48B USD | $0 0 USD | $500.2 546.79 USD | $509.8 557.28 USD | $30.63B 33.48B USD | 34.90 | $14.33 15.66 USD | |
| UCB SA UNC.F | $161.05 176.05 USD |
-0.37
|
$30.61B 33.46B USD | $15 16.4 USD | $161.05 176.05 USD | $161.05 176.05 USD | $30.61B 33.46B USD | 29.38 | $5.48 5.99 USD | |
| UCB SA UNC0.F | $79.5 86.9 USD |
+1.27
|
$30.59B 33.44B USD | $50 54.66 USD | $79.5 86.9 USD | $79.5 86.9 USD | $30.59B 33.44B USD | 29.01 | $2.74 3 USD | |
| UCB SA UCB.VI | $160.7 175.67 USD |
-0.16
|
$30.54B 33.38B USD | $0 0 USD | $160.7 175.67 USD | $163 178.18 USD | $30.54B 33.38B USD | 29.37 | $5.47 5.98 USD | |
| BioNTech SE B1NT34.SA | $38.44 7.79 USD |
-2.83
|
$147.85B 29.97B USD | $0 0 USD | $0 0 USD | $0 0 USD | $147.85B 29.97B USD | 0 | -$1.28 -0.2 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| BeOne Medicines Ltd. 49BA.F | $222 242.68 USD |
-0.89
|
$25.63B 28.02B USD | $25 27.33 USD | $222 242.68 USD | $222 242.68 USD | $25.63B 28.02B USD | 0 | -$3.2 -3.4 USD | |
| BeOne Medicines Ltd. 49B.F | $16.51 18.04 USD |
-1.96
|
$25.36B 27.72B USD | $509 556.41 USD | $16.51 18.04 USD | $16.51 18.04 USD | $25.36B 27.72B USD | 0 | -$0.25 -0.2 USD | |
| Celltrion, Inc. 068270.KS | $163,100 123.11 USD |
+1.62
|
$35.51T 26.8B USD | $529.38K 399.6 USD | $160,200 120.92 USD | $163,400 123.34 USD | $35.51T 26.8B USD | 0 | $0 0 USD | |
| BioNTech SE BNTX.VI | $97.25 106.31 USD |
-1.62
|
$23.38B 25.56B USD | $370 404.46 USD | $97.25 106.31 USD | $99.6 108.88 USD | $23.38B 25.56B USD | 0 | -$3.19 -3.4 USD | |
| BioNTech SE 22UA.F | $96.8 105.82 USD |
-2.07
|
$23.27B 25.44B USD | $2.49K 2.72K USD | $96 104.94 USD | $99.9 109.2 USD | $23.27B 25.44B USD | 0 | -$3.19 -3.4 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.F | $29.02 31.72 USD |
+0.1
|
$16.53B 18.07B USD | $15 16.4 USD | $29.02 31.72 USD | $29.02 31.72 USD | $16.53B 18.07B USD | 13.49 | $2.15 2.35 USD | |
| Royalty Pharma plc RPD.MU | $29.07 31.78 USD |
0
|
$16.52B 18.05B USD | $0 0 USD | $0 0 USD | $0 0 USD | $16.52B 18.05B USD | 13.52 | $2.15 2.35 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,480 87.63 USD |
0
|
$283.83B 16.81B USD | $0 0 USD | $1,480 87.63 USD | $1,480 87.63 USD | $283.83B 16.81B USD | 28.48 | $51.95 3.08 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Innovent Biologics IVBXF | $9.5 — |
+15.15
|
$15.56B — | $850 — | $9.01 — | $9.5 — | $15.56B — | 0 | -$0.01 — | |
| Incyte Corporation I1NC34.SA | $171.27 34.71 USD |
0
|
$73.62B 14.92B USD | $0 0 USD | $0 0 USD | $0 0 USD | $73.62B 14.92B USD | 300.47 | $0.57 0.12 USD | |
| Incyte Corporation INCY.MX | $1,180.69 69.91 USD |
0
|
$251.28B 14.88B USD | $0 0 USD | $0 0 USD | $0 0 USD | $251.28B 14.88B USD | 302.74 | $3.9 0.23 USD | |
| Innovent Biologics, Inc. 6IB.F | $7.9 8.64 USD |
-7.06
|
$12.94B 14.15B USD | $5.07K 5.54K USD | $7.75 8.47 USD | $8.35 9.13 USD | $12.94B 14.15B USD | 0 | -$0.01 -0.01 USD | |
| United Therapeutics Corporation UTH.F | $281.6 307.83 USD |
-0.53
|
$12.77B 13.96B USD | $15 16.4 USD | $281.6 307.83 USD | $281.6 307.83 USD | $12.77B 13.96B USD | 12.77 | $22.05 24.1 USD | |
| Genmab A/S GNMSF | $218.13 — |
+2.89
|
$13.52B — | $6 — | $218.13 — | $218.13 — | $13.52B — | 12.80 | $17.04 — | |
| Insmed Incorporated IM8N.F | $67 73.24 USD |
+4.69
|
$12.2B 13.34B USD | $130 142.11 USD | $64.5 70.51 USD | $67 73.24 USD | $12.2B 13.34B USD | 0 | -$5.19 -5.6 USD | |
| WuXi Biologics (Cayman) WXIBF | $3.2 — |
0
|
$13.07B — | $400 — | $3.2 — | $3.2 — | $13.07B — | 29.09 | $0.11 — | |
| Genmab A/S GMAB.VI | $192.45 210.37 USD |
-0.26
|
$11.85B 12.96B USD | $0 0 USD | $189.5 207.15 USD | $192.45 210.37 USD | $11.85B 12.96B USD | 12.93 | $14.88 16.27 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $164 33.24 USD |
0
|
$62.9B 12.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $62.9B 12.75B USD | 21.55 | $7.61 1.54 USD | |
| Insmed Incorporated IM8N.SG | $63.5 69.41 USD |
-0.78
|
$11.6B 12.68B USD | $0 0 USD | $63.5 69.41 USD | $65 71.05 USD | $11.6B 12.68B USD | 0 | -$5.19 -5.6 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Incyte Corporation ICY.F | $58.84 64.32 USD |
+0.1
|
$11.48B 12.55B USD | $17 18.58 USD | $58.84 64.32 USD | $58.84 64.32 USD | $11.48B 12.55B USD | 326.88 | $0.18 0.2 USD | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.76 3.02 USD |
-3.12
|
$11.23B 12.28B USD | $840 918.23 USD | $2.73 2.98 USD | $2.76 3.02 USD | $11.23B 12.28B USD | 27.60 | $0.1 0.11 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.4 5.9 USD |
-3.57
|
$10.99B 12.01B USD | $208 227.37 USD | $5.4 5.9 USD | $5.4 5.9 USD | $10.99B 12.01B USD | 28.42 | $0.19 0.21 USD | |
| Ascendis Pharma A/S A1SN34.SA | $65.49 13.27 USD |
-0.92
|
$58.72B 11.9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $58.72B 11.9B USD | 0 | -$37.31 -7.5 USD | |
| Moderna, Inc. MRNA.MX | $509.5 30.17 USD |
-2.72
|
$197.54B 11.7B USD | $62 3.67 USD | $509.5 30.17 USD | $521 30.85 USD | $197.54B 11.7B USD | 0 | -$168 -9.9 USD | |
| Exelixis, Inc. EX9.F | $36.62 40.03 USD |
-1.48
|
$10.11B 11.06B USD | $230 251.42 USD | $36.62 40.03 USD | $36.62 40.03 USD | $10.11B 11.06B USD | 19.07 | $1.92 2.1 USD | |
| Verona Pharma plc I9SA.F | $71.8 78.49 USD |
-5.53
|
$9.97B 10.9B USD | $260 284.22 USD | $71.8 78.49 USD | $76.4 83.52 USD | $9.97B 10.9B USD | 0 | -$1.75 -1.9 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.55 — |
-3.37
|
$10.54B — | $1.26K — | $0.55 — | $0.55 — | $10.54B — | 55.27 | $0.01 — | |
| Sino Biopharmaceutical SBHMY | $9.48 — |
+7.85
|
$10.54B — | $321 — | $9.48 — | $9.48 — | $10.54B — | 32.68 | $0.29 — | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $49.09 53.66 USD |
-1.47
|
$9.41B 10.29B USD | $0 0 USD | $48.75 53.29 USD | $49.22 53.8 USD | $9.41B 10.29B USD | 20.71 | $2.37 2.59 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $48.92 53.48 USD |
-1.61
|
$9.38B 10.26B USD | $50 54.66 USD | $48.91 53.47 USD | $48.92 53.48 USD | $9.38B 10.26B USD | 20.72 | $2.36 2.58 USD | |
| Ascendis Pharma A/S A71.F | $151 165.06 USD |
-1.31
|
$9.13B 9.99B USD | $60 65.59 USD | $151 165.06 USD | $151 165.06 USD | $9.13B 9.99B USD | 0 | -$5.81 -6.3 USD | |
| Moderna, Inc. MRNA.VI | $23.53 25.72 USD |
-3.29
|
$9.1B 9.95B USD | $1.44K 1.57K USD | $23.06 25.2 USD | $24.03 26.27 USD | $9.1B 9.95B USD | 0 | -$7.62 -8.3 USD | |
| Moderna, Inc. 0QF.MU | $23.28 25.45 USD |
-5.21
|
$9B 9.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $9B 9.84B USD | 0 | -$7.67 -8.3 USD | |
| Moderna, Inc. 0QF.F | $22.8 24.92 USD |
-7.68
|
$8.82B 9.64B USD | $1.58K 1.72K USD | $22.8 24.92 USD | $24.23 26.49 USD | $8.82B 9.64B USD | 0 | -$7.67 -8.3 USD | |
| Akeso, Inc. 4RY.F | $9.05 9.89 USD |
+1.12
|
$8.25B 9.01B USD | $172 188.02 USD | $9.05 9.89 USD | $9.1 9.95 USD | $8.25B 9.01B USD | 0 | -$0.07 -0.07 USD | |
| Bio-Techne Corporation TECH.MX | $956.78 56.65 USD |
-34.87
|
$152.02B 9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $152.02B 9B USD | 37.66 | $25.4 1.5 USD | |
| Bio-Techne Corporation T1CH34.SA | $9.39 1.9 USD |
0
|
$44.16B 8.95B USD | $0 0 USD | $0 0 USD | $0 0 USD | $44.16B 8.95B USD | 58.68 | $0.16 0.03 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Cerevel Therapeutics CERE | $44.96 — |
0
|
$8.19B — | $0 — | $0 — | $0 — | $8.19B — | 0 | $0 — | |
| Blueprint Medicines Corporation 2L9.F | $111.5 121.88 USD |
-1.28
|
$7.24B 7.92B USD | $120 131.18 USD | $111.5 121.88 USD | $111.5 121.88 USD | $7.24B 7.92B USD | 0 | -$2.2 -2.4 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $1,018.51 60.31 USD |
+0.97
|
$127.76B 7.57B USD | $300 17.76 USD | $1,018.51 60.31 USD | $1,018.51 60.31 USD | $127.76B 7.57B USD | 14.10 | $72.21 4.28 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.79B 7.42B USD | 0 | $0 0 USD | |
| Roivant Sciences Ltd. 87S.F | $9.6 10.49 USD |
+0.04
|
$6.66B 7.28B USD | $600 655.88 USD | $9.6 10.49 USD | $9.71 10.61 USD | $6.66B 7.28B USD | 0 | -$0.66 -0.7 USD | |
| Bio-Techne Corporation TE1.F | $41.8 45.69 USD |
-3.69
|
$6.61B 7.23B USD | $50 54.66 USD | $41.8 45.69 USD | $43 47 USD | $6.61B 7.23B USD | 57.26 | $0.73 0.8 USD | |
| Revolution Medicines, Inc. 42Z.F | $35 38.26 USD |
-0.57
|
$6.57B 7.18B USD | $86 94.01 USD | $35 38.26 USD | $35 38.26 USD | $6.57B 7.18B USD | 0 | -$3.52 -3.8 USD | |
| Corcept Therapeutics Incorporated HTD.F | $60.28 65.89 USD |
-1.34
|
$6.43B 7.03B USD | $115 125.71 USD | $60.28 65.89 USD | $60.76 66.42 USD | $6.43B 7.03B USD | 59.68 | $1.01 1.1 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $32.97 36.04 USD |
+0.83
|
$6.39B 6.99B USD | $100 109.31 USD | $32.97 36.04 USD | $32.97 36.04 USD | $6.39B 6.99B USD | 0 | -$3.13 -3.4 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $18.75 20.5 USD |
-3.1
|
$6.34B 6.93B USD | $50 54.66 USD | $18.75 20.5 USD | $18.75 20.5 USD | $6.34B 6.93B USD | 0 | -$4.43 -4.8 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $94.86 103.69 USD |
-1.29
|
$5.85B 6.39B USD | $20 21.86 USD | $94.54 103.34 USD | $95.98 104.92 USD | $5.85B 6.39B USD | 14.66 | $6.47 7.07 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $647 38.31 USD |
0
|
$107.59B 6.37B USD | $0 0 USD | $0 0 USD | $0 0 USD | $107.59B 6.37B USD | 0 | -$57.45 -3.4 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $46.96 51.33 USD |
+0.32
|
$5.79B 6.33B USD | $9 9.84 USD | $46.94 51.31 USD | $46.96 51.33 USD | $5.79B 6.33B USD | 14.27 | $3.29 3.6 USD | |
| Financière de Tubize SA FTD.SG | $127.6 139.48 USD |
+1.59
|
$5.68B 6.21B USD | $0 0 USD | $126.4 138.17 USD | $127.6 139.48 USD | $5.68B 6.21B USD | 63.16 | $2.02 2.21 USD | |
| ALK-Abelló A/S AKBLF | $26.99 — |
+4.01
|
$6.18B — | $2 — | $26.99 — | $27.05 — | $6.18B — | 42.17 | $0.64 — | |
| Financière de Tubize SA FTD.F | $126.4 138.17 USD |
+0.64
|
$5.63B 6.15B USD | $70 76.52 USD | $126.4 138.17 USD | $126.4 138.17 USD | $5.63B 6.15B USD | 62.57 | $2.02 2.21 USD | |
| ALK-Abelló A/S 4AJ0.F | $24.62 26.91 USD |
+0.08
|
$5.43B 5.94B USD | $2 2.19 USD | $24.28 26.54 USD | $24.66 26.96 USD | $5.43B 5.94B USD | 43.96 | $0.56 0.61 USD | |
| Telix Pharmaceuticals TLPPF | $17.16 — |
-1.94
|
$5.89B — | $1.14K — | $17.16 — | $17.16 — | $5.89B — | 190.66 | $0.09 — | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $238.8 261.04 USD |
-2.25
|
$5.33B 5.82B USD | $50 54.66 USD | $237.7 259.84 USD | $242.3 264.87 USD | $5.33B 5.82B USD | 0 | -$15.67 -17.1 USD | |
| 3SBio Inc. 83B.F | $2.14 2.34 USD |
-0.93
|
$5.13B 5.61B USD | $150 163.97 USD | $2.1 2.3 USD | $2.14 2.34 USD | $5.13B 5.61B USD | 21.40 | $0.1 0.11 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||